These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8732374)

  • 1. Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project.
    Boissel JP; Castaigne A; Mercier C; Lion L; Leizorovicz A
    Eur Heart J; 1996 Feb; 17(2):213-21. PubMed ID: 8732374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis-associated ventricular fibrillation: is it reperfusion, the drug or what?
    Verheugt FW
    Eur Heart J; 1996 Feb; 17(2):172-3. PubMed ID: 8732368
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.
    European Myocardial Infarction Project Group
    N Engl J Med; 1993 Aug; 329(6):383-9. PubMed ID: 8326971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The European Myocardial Infarction Project: an assessment of pre-hospital thrombolysis.
    Boissel JP
    Int J Cardiol; 1995 Aug; 49 Suppl():S29-37. PubMed ID: 7591314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-hospital and hospital time delays in thrombolytic treatment in patients with suspected acute myocardial infarction. Analysis of data from the EMIP study. European Myocardial Infarction Project.
    Leizorovicz A; Haugh MC; Mercier C; Boissel JP
    Eur Heart J; 1997 Feb; 18(2):248-53. PubMed ID: 9043841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.
    BMJ; 1992 Sep; 305(6853):548-53. PubMed ID: 1393033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of left ventricular function after acute myocardial infarction: efficacy of domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial.
    Rawles JM
    Coron Artery Dis; 1993 Sep; 4(9):801-8. PubMed ID: 8287214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended mortality benefit of early postinfarction reperfusion.
    Rawles J
    Circulation; 1998 Dec 22-29; 98(25):2934-5. PubMed ID: 9860801
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of quality adjusted days as a trial endpoint: effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT).
    Rawles J; Light J
    J Epidemiol Community Health; 1993 Oct; 47(5):377-81. PubMed ID: 8289038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators.
    Volpi A; Cavalli A; Santoro E; Tognoni G
    Circulation; 1990 Oct; 82(4):1279-88. PubMed ID: 2205418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).
    Rawles JM
    J Am Coll Cardiol; 1997 Nov; 30(5):1181-6. PubMed ID: 9350912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patients with acute myocardial infarction with and without ventricular fibrillation.
    Brezins M; Elyassov S; Elimelech I; Roguin N
    Am J Cardiol; 1996 Oct; 78(8):948-50. PubMed ID: 8888673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B; Calçada-Correia L; Pedro PG; Conduto R; Dionísio I; Fiuza M; Dias E; Vaz Carneiro A; Amador MG; de Pádua F; Lopes MG
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of left ventricular function as an end point of thrombolytic therapy.
    Bassand JP; Anguenot T; Cassagnes J; Lusson JR; Machecourt J; Wolf JE
    Am J Cardiol; 1991 Dec; 68(16):23E-29E. PubMed ID: 1746448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved left ventricular function in myocardial infarction following intravenous thrombolytic therapy with acylated plasminogen activator.
    Ovsyshcher I; Silber H; Hausman MI; Margolis G; Gueron M
    Angiology; 1990 Feb; 41(2):133-8. PubMed ID: 2407157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
    Ghaffari S; Kazemi B; Golzari IG
    Cardiovasc Ther; 2013 Feb; 31(1):53-9. PubMed ID: 21884018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.